Departure or Appointment of Directors or Certain Officers
→
4/25/25
Vote
Amendments to Articles of Incorporation or Bylaws
→
1/7/25
Agreement
Entry into a Material Definitive Agreement
→
4/24/24
Vote
Submission of Matters to a Vote of Security Holders
→
1/26/24
Exec Change
REVVITY, INC. 8-K
→
4/28/23
Vote
Amendments to Articles of Incorporation or Bylaws
→
↓
Prospectuses & Registrations
32 shown
Filed
Form
Description
3/12/25
ARS
ARS
→
2/28/25
S-3ASR
S-3ASR
→
12/4/24
S-8
S-8
→
3/13/24
ARS
ARS
→
3/8/23
ARS
ARS
→
3/25/22
S-8
S-8
→
↓
Filing History(1001 filings)
TypeDateAccessionPeriodSize
4
Mar 10, 2026
0001193125-26-1001184
Mar 6, 2026
7.0 KB
PRE 14A
Mar 6, 2026
0001193125-26-096497PRE 14A
Apr 28, 2026
4.3 MB
4
Feb 26, 2026
0001193125-26-0765434
Feb 24, 2026
8.4 KB
4
Feb 25, 2026
0001193125-26-0715224
Feb 23, 2026
5.0 KB
10-K
Feb 24, 2026
0000031791-26-00001210-K
Dec 28, 2025
17.1 MB
144
Feb 24, 2026
0001959173-26-001398
—
4.5 KB
144
Feb 23, 2026
0001959173-26-001329
—
4.4 KB
4
Feb 19, 2026
0001193125-26-0593434
Feb 17, 2026
4.9 KB
4
Feb 19, 2026
0001193125-26-0593424
Feb 17, 2026
5.0 KB
4
Feb 19, 2026
0001193125-26-0593444
Feb 17, 2026
8.1 KB
4
Feb 19, 2026
0001193125-26-0593454
Feb 17, 2026
6.5 KB
4
Feb 19, 2026
0001193125-26-0593404
Feb 17, 2026
6.1 KB
4
Feb 19, 2026
0001193125-26-0593394
Feb 17, 2026
6.1 KB
SCHEDULE 13G/A
Feb 17, 2026
0001897612-26-000258
—
9.3 KB
4
Feb 6, 2026
0001193125-26-0411524
Feb 4, 2026
9.1 KB
4
Feb 6, 2026
0001193125-26-0411584
Feb 4, 2026
23.1 KB
4
Feb 6, 2026
0001193125-26-0411514
Feb 4, 2026
21.3 KB
4
Feb 6, 2026
0001193125-26-0411574
Feb 4, 2026
9.1 KB
4
Feb 6, 2026
0001193125-26-0411504
Feb 4, 2026
9.0 KB
144
Feb 5, 2026
0001959173-26-000678
—
4.6 KB
144
Feb 5, 2026
0001959173-26-000673
—
4.5 KB
4
Feb 4, 2026
0001193125-26-0375514
Feb 2, 2026
8.5 KB
144
Feb 2, 2026
0001959173-26-000515
—
4.6 KB
8-K
Feb 2, 2026
0000031791-26-0000078-K
Feb 2, 2026
565.4 KB
8-K
Jan 13, 2026
0000031791-26-0000038-K
Jan 12, 2026
3.2 MB
25 filings shown
Proxies
33 shown
Filed
Form
Description
3/6/26
PRE 14A
PRE 14A
→
3/12/25
DEFA14A
DEFA14A
→
3/12/25
DEF 14A
DEF 14A
→
2/26/25
PRE 14A
PRE 14A
→
3/13/24
DEFA14A
DEFA14A
→
3/13/24
DEF 14A
DEF 14A
→
↓
Ownership
40 shown
Filed
Form
Description
3/10/26
4
4
→
2/26/26
4
4
→
2/25/26
4
4
→
2/19/26
4
4
→
2/19/26
4
4
→
2/19/26
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
2/24/26
144
144
→
2/23/26
144
144
→
2/17/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
2/5/26
144
144
→
2/5/26
144
144
→
2/2/26
144
144
→
↓
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments.